Thai Drug Maker Says Second H1N1 Seed Virus Produces Higher Yield
This article was originally published in PharmAsia News
Executive Summary
A Thailand drug maker reports its second batch of seed virus has proved successful in delivering a higher yield of H1N1 flu vaccine. The Government Pharmaceutical Organization's director said the quality of seed virus liquid in the second batch also is better than that of the first. The second batch of seed virus was sought from a foreign supplier after the first provided a yield considered too low to be useful. (Click here for more